Recording of transmembrane action potentials in chronic ischemic heart disease and dilated cardiomyopathy and the effects of the new class III antiarrhythmic agents D-sotalol and dofetilide

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 4, 1996, Pages 571-577

  Montero, Maria ^a   Schmitt, Claus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Effects of D sotalol and dofetilide; Endocardial action potentials; Human dilated cardiomyopathy and chronic ischemic heart disease

Indexed keywords

ANTIARRHYTHMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOFETILIDE; SOTALOL;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOCARDIUM; HEART DILATATION; HEART MUSCLE FIBER MEMBRANE STEADY POTENTIAL; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART REPOLARIZATION; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; ISOLATED HEART; PRIORITY JOURNAL; REGIONAL PERFUSION;

ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHIES; CORONARY DISEASE; HEART; HEART VENTRICLES; HUMANS; MEMBRANE POTENTIALS; PHENETHYLAMINES; SOTALOL; SULFONAMIDES;

EID: 0029922876     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199604000-00017     Document Type: Article

References (35)

1. Haffaje CI, Lowe JC, Canada AT, Lesko LJ, Asdourian G, Albert JS. Clinical pharmacokokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation 1983; 67:1347-53.
2. Nademanee K, Feld G, Hendrikson J, Singh PN, Singh BN. Electrophysiological and antiaarrhythmic effects of sotalol on patients with life-threatening ventricular tachyarrhythmias. Circulation 1985;72:555-64.
3. Singh BN, Vaughan Williams EM. The effect of amiodarone, a new antanginal drug on cardiac muscle. Br J Pharmacol 1970;39:657-67.
4. Strauss HC, Bigger JT, Hofman BF. Electrophysiological and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res 1970;26:661-78.
5. CAST Investigators: mortality and morbidity in patients receiving encainide, flecainide or placebo. N Engl J Med 1991; 324:783-8.
6. Singh BN, Nademanee K. Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic consideration and clinical observations. Am Heart J 1985;109:21-30.
7. Gwilt M, Solca RA, Burges RA, Blackburn KJ, Higgins AJ. Antifibrillatory action and haemodynamic properties of UK-68,798, a new class III antiarrhythmic agent, in anaesthetized dogs. J Mol Cell Cardiol 1989;21(suppl II):32.
8. Gwilt M, Dalrymple HW, Burges RA, et al. UK-68,798 is a novel, potent and selective class III antiarrhythmic drug. J MoI Cell Cardiol 1989;21(suppl II):31.
9. Schlepper M. Cardiodepressive effects of antiarrhythmic drugs. Eur Heart J 1989;10(suppl E):73-80.
10. Waldo AL, Camm AJ, de Ruyter H, et al., for the Sword Investigators. Preliminary mortality results from the survival with oral D-sotalol (SWORD) Trial. J Am Coll Cardiol 1995.
11. Nabauer M, Beuckelmann DJ, Erdmann E. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73: 396-94.
12. Beuckelmann DJ, Nabaur M, Erdmann E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73:379-85.
13. Wettwer E, Amos G, Gath J, Zerlowiski HR, Reidemeister JC, Ravens U. Transient outward current in human and rat ventricular myocytes. Cardiovasc Res 1993;27:1662-9.
14. Powell T, Sturridge MF, Suvarna SK, Terrar DA, Twist VW. Intact individual heart cells isolated from human ventricular tissue. Br J Med 1981;283:1013-5.
15. Nanasi PP, Varro A, Lathrop DA. Ionic currents in ventricular myocytes from the hearts of a patient with idiopathic cardiomyopathy. Cardioscience 1992;3:85-9.
16. Franz MR. Longterm recording of monophasic action potentials from human myocardium. Am J Cardiol 1985;51:1629-34.
17. Schmitt C, Brachmann J, Karch M, et al. Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle. Am J Cardiol 1991;68:1183-7.
18. Sakakibara Y, Furukawa T, Singer DH, et al. Sodium current in isolated human ventricular myocytes. Am J Physiol 1993;265:H1301-9.
19. CIBIS Investigators and committees. A randomized trial of β-blockade in heart failure. The cardiac insufficiency bisoprolol study (CIBIS). Circulation 1994;90:1765-73.
20. Singh SN, Fletcher RD, Fisher SG, et al., for the survival trial of antiarrhythmic therapy in congestive heart failure. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333:77-82.
21. + channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Circulation 1995;92:164-74.
22. 1 (in human hearts with dilated but not ischemic cardiomyopathy). Circulation 1990;82: 1249-65.
23. Trautwein W, Kassebaum DG, Nelson RM, Hecht HH. Electrophysiological study of human heart muscle. Circ Res 1962;10:306-12.
24. Mitchell MR, Powel T, Sturridge MF, Terrar DA, Twist VW. Electrical properties and response to noradrenaline of individual heart cells isolated from human ventricular tissue. Cardiovasc Res 1986;20:869-76.
25. Gilmour RF, Heger JJ, Prystowsky EN, et al. Cellular electrophysiologic abnormalities of diseased human ventricular myocardium. Am J Cardiol 1983;51:137-44.
26. Carmeliet E. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. J Pharmacol Exp Ther 1985;232:817-24.
27. Montero M, Schmitt C. Differential effects of D-sotalol on human endocardia! and epicardial transmembrane action potentials. J Cardiovasc Pharmacol 1994;24:883-9.
28. Spear JF, Horowitz LN, Hodess AB, et al. Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation. Circulation 1979;59:247-56.
29. Mubagwa K, Flameng W, Carmeliet E. Resting and action potentials of nonischemic and chronically ischemic human ventricular muscle. J Cardiovasc Electrophysiol 1994;5:659-71.
30. Schmitt C, Beyer T, Karch M, et al. Characteristics of endocardial monophasic action potentials recorded from areas with fractionated bipolar electrograms in infarcted canine ventricular myocardium. Cardiovascular Res 1991;25:984-7.
31. Gardner PI, Ursell PC, Fenoglio JJ, Wit A. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 1985; 72:596-611.
32. Campbell TJ. Cellular electrophysiological effects of D- and DL-sotalol in guinea pig sinoatrial node, atrium and ventricle and human atrium: differential tissue sensitivity. Br J Pharmacol 1987;90:593-9.
33. k blocking drug, effect in rat myocardium. J Cardiovasc Pharmacol 1990;16: 401-10.
34. Schmitt C, Beyer T, Karch M, et al. Sotalol exhibits reverse use-dependent action on monophasic action potentials in normal but not in infarcted canine ventricular myocardium. J Cardiovasc Pharmacol 1992;19:487-92.
35. Montero M, Beyer T, Schmitt C, Kübler W, Brachmann J. Differential effects of quinidine on transmembrane action potentials of normal and infarcted canine fibers. J Cardiovasc Pharmacol 1992;20:304-10.